Literature DB >> 9317031

Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

H A Haeberle1, M Kubin, K B Bamford, R Garofalo, D Y Graham, F El-Zaatari, R Karttunen, S E Crowe, V E Reyes, P B Ernst.   

Abstract

The objective of these experiments was to examine the ability of Helicobacter pylori to stimulate interleukin-10 (IL-10) or IL-12 and select for either Th1 or Th2 cells. Gastric biopsy specimens were collected from patients who were categorized with respect to the presence of H. pylori and gastric disease as well as their age, gender, medications, and other factors. As Th1 and Th2 cells are selected by IL-12 and IL-10, respectively, biopsy specimens were screened for mRNA and protein for these cytokines. Although mRNA for IL-12 and IL-10 was detected in biopsy specimens obtained from both infected and uninfected patients, IL-12 protein predominated. Levels of IL-10 and IL-12 in gastric tissue did not change in response to infection. Moreover, gamma interferon (IFN-gamma)-producing T cells were found in both the infected and the uninfected gastric mucosa. Stimulation of peripheral blood leukocytes from either infected or uninfected donors with various concentrations of live or killed H. pylori induced immunoreactive IL-12 and IL-10. After stimulation with live H. pylori, IL-12 levels increased more than 30-fold, whereas IL-10 levels increased only 2- to 5-fold, compared to cells stimulated with medium alone. Interestingly, killed H. pylori induced significantly more IL-10 (P < 0.05) than live H. pylori, while recombinant urease only induced IL-10. These results demonstrate that live H. pylori selectively stimulates the induction of IL-12 and Th1 cells that produce IFN-gamma, whereas preparations used in oral vaccines induce more IL-10 and may favor Th2 cell responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317031      PMCID: PMC175607          DOI: 10.1128/iai.65.10.4229-4235.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro.

Authors:  S E Crowe; L Alvarez; M Dytoc; R H Hunt; M Muller; P Sherman; J Patel; Y Jin; P B Ernst
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

2.  Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients.

Authors:  P Gionchetti; D Vaira; M Campieri; J Holton; M Menegatti; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; M Miglioli
Journal:  Am J Gastroenterol       Date:  1994-06       Impact factor: 10.864

3.  Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis.

Authors:  A Greiner; A Marx; J Heesemann; J Leebmann; B Schmausser; H K Müller-Hermelink
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

Review 4.  Pathophysiology of Helicobacter pylori infection.

Authors:  M F Dixon
Journal:  Scand J Gastroenterol Suppl       Date:  1994

5.  Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection.

Authors:  R L Ferrero; J M Thiberge; M Huerre; A Labigne
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.

Authors:  P Michetti; I Corthésy-Theulaz; C Davin; R Haas; A C Vaney; M Heitz; J Bille; J P Kraehenbuhl; E Saraga; A L Blum
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

7.  Interleukin-12 production by human polymorphonuclear leukocytes.

Authors:  M A Cassatella; L Meda; S Gasperini; A D'Andrea; X Ma; G Trinchieri
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

8.  Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation.

Authors:  X J Fan; A Chua; C N Shahi; J McDevitt; P W Keeling; D Kelleher
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

9.  Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro.

Authors:  H P Vollmers; J Dämmrich; H Ribbert; S Grassel; S Debus; J Heesemannn; H K Müller-Hermelink
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

10.  Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.

Authors:  P Ling; M K Gately; U Gubler; A S Stern; P Lin; K Hollfelder; C Su; Y C Pan; J Hakimi
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

View more
  47 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.

Authors:  M Eck; B Schmausser; K Scheller; A Toksoy; M Kraus; T Menzel; H K Müller-Hermelink; R Gillitzer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration.

Authors:  N Hida; T Shimoyama; P Neville; M F Dixon; A T Axon; T Shimoyama; J E Crabtree
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 4.  Immune response to H. pylori.

Authors:  Giovanni Suarez; Victor E Reyes; Ellen J Beswick
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

5.  A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence.

Authors:  M S Alam; C C Kurtz; J M Wilson; B R Burnette; E B Wiznerowicz; W G Ross; J M Rieger; R A Figler; J Linden; S E Crowe; P B Ernst
Journal:  Mucosal Immunol       Date:  2009-03-04       Impact factor: 7.313

6.  Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection.

Authors:  Ellen J Beswick; Iryna V Pinchuk; Rachel B Earley; David A Schmitt; Victor E Reyes
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

7.  Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions.

Authors:  J Wang; X Fan; C Lindholm; M Bennett; J O'Connoll; F Shanahan; E G Brooks; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

8.  Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells.

Authors:  David J Mitchell; Hien Q Huynh; Peter J M Ceponis; Nicola L Jones; Philip M Sherman
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice.

Authors:  Mohammad S Alam; Courtney C Kurtz; Robert M Rowlett; Brian K Reuter; Elizabeth Wiznerowicz; Soumita Das; Joel Linden; Sheila E Crowe; Peter B Ernst
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

10.  Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation.

Authors:  Junzo Hisatsune; Masaaki Nakayama; Hajime Isomoto; Hisao Kurazono; Naofumi Mukaida; Asish K Mukhopadhyay; Takeshi Azuma; Yoshio Yamaoka; Jan Sap; Eiki Yamasaki; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.